The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts work in real-world settings (everyday medical practice). The aim is to study approximately 100 patients in European hospitals, with competitive enrollment.
Implantation of a Castor™ or Cratos™ single branch endoprothesis with incorporation of the left subclavian artery
Age >18 years
Patients allergic to the materials of the device;
Patients with severe or potentially systemic infections that increase the chance of graft infection;
Minors and pregnant women;
Branch for other supra-aortic vessels than the LSA
Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
Lead sponsor